A Philadelphia jury recently awarded $2.5 million in damages to a 20-year old man who developed gynecomastia (enhancement of male breasts) after taking the prescription drug risperdal. The jury found that Janssen, a subsidiary of Johnson & Johnson, failed to adequately warn users of this side-effect of the drug. The plaintiff was represented at trial by the Philadelphia firm of Kline & Specter, PC. If you or someone you know has experienced side effects from taking risperdal, Gainsburgh Benjamin’s products liability attorneys are available for an initial case screening.
